Key Takeaways
- Laza Medical Series B: up to $160 million, led by GE HealthCare, announced November 5, 2026.
- Laza Medical funding history: $36 million in financing in December 2023, with GE HealthCare in that round too.
- Laza Medical funding multiple: the $160 million ceiling is 4.4 times the 2023 financing.
- Laza Medical AI imaging: technology designed to simplify procedures in the cath lab, after a first-in-human clinical study.
Laza Medical Series B financing of up to $160 million was led by GE HealthCare, according to the California medtech company's announcement on November 5, 2026. Three returning investors also took part.
Cardiovascular Business reports that Laza Medical secured $36 million in financing in December 2023, and that GE HealthCare was involved with that round as well. Measured at the $160 million ceiling, the Series B is 4.4 times that earlier amount.
Laza Medical funding history: $36 million in 2023, up to $160 million in 2026
A Series B is a later round of venture funding, raised after a startup has already taken outside money. Cardiovascular Business reports that Laza Medical secured $36 million in financing in December 2023, and that GE HealthCare also participated in a previous financing round in 2023. The new round was described as up to $160 million, which is $124 million more than the earlier financing at the ceiling.
The multiple, meaning the ratio of the two amounts, is simple arithmetic: 160 divided by 36 is 4.44, which rounds to 4.4. Because the company's press release says up to $160 million, the multiple is also a ceiling, meaning a maximum. If the final amount is below $160 million, the multiple falls below 4.4.
What Laza Medical's AI imaging system is built to do in the cath lab
Medtech is short for medical technology. A cath lab, short for cardiac catheterization laboratory, is the hospital room where doctors diagnose and treat heart problems using thin tubes called catheters and imaging guidance. The press release says the financing will support Laza Medical's mission to transform that room through intelligent imaging technology designed to simplify procedures, increase autonomy, alleviate resource constraints, and unlock possibilities for future robotic-enabled interventions.
The press release also says a first-in-human clinical study of the software took place last year. A first-in-human study is the first time a product is tested in people.
"The cath lab is poised for a fundamental evolution, and intelligent imaging powered by AI will play a defining role in what comes next," said Amr Salahieh, Founder and Board Chairman at Laza Medical.
"The future of cardiac intervention must be one where access, consistency, and quality of care are no longer barriers to better outcomes," said Jyoti Gera, CEO of cardiovascular and interventional solutions at GE HealthCare. Gera added: "Integrating imaging modalities so they work seamlessly together has the potential to redefine the cath lab, enabling more efficient workflows today and paving the way for smarter, robotic procedures tomorrow."
GE HealthCare and Laza Medical: why a repeat investment matters
Gera said GE HealthCare is excited to expand its collaboration with Laza Medical. That wording points to a collaboration that already exists, rather than a first-time partnership, and it fits an investor that backed the company's earlier financing and now leads the Series B.
The reporting supports one narrow claim: GE HealthCare backed Laza Medical in two financings. The newer amount is only a ceiling, so the 4.4 multiple is a maximum, not a final ratio.
For readers following cath lab technology, the gap between a ceiling and a final amount is the number to watch. A later announcement with a final amount would give an exact multiple.
People Also Ask
How much did Laza Medical raise in its Series B?
Laza Medical announced on November 5, 2026 that it raised up to $160 million in Series B financing. GE HealthCare led the round, and three returning investors also took part.
How does the Laza Medical Series B compare with its 2023 financing?
Cardiovascular Business reports that Laza Medical secured $36 million in financing in December 2023, with GE HealthCare involved. At the $160 million ceiling of the Series B, the new financing is 4.4 times the 2023 amount.
What does Laza Medical do?
Laza Medical is a California-based medtech company that works on AI-powered robotic imaging solutions for cardiac interventions. The company says its intelligent imaging technology is designed to simplify procedures and unlock possibilities for future robotic-enabled interventions.
Is the Laza Medical Series B amount final?
Laza Medical's announcement describes the Series B as up to $160 million, so the figure is a ceiling rather than a confirmed final amount. The $160 million is the top of that range, and the 4.4 multiple above is calculated from that top figure.
Sources: Cardiovascular Business, Macau Business.